Particle.news
Download on the App Store

Prosecutors Inspect Almenara Over Oncology Drug Shortages as EsSalud Cites 93% Pharmacy Stock

Prosecutors warned the documented gaps could trigger criminal liability, prompting urgent procurement of oncology medicines.

Overview

  • The Lima Centro Prevention of Crime office conducted an on‑site inspection on Feb. 9 at Hospital Guillermo Almenara led by prosecutor Roldán Soto Salazar.
  • The review covered Pharmacy, Emergency, ICU and Intermediate Care, with participation from SUSALUD, EsSalud, DIRIS Lima Sur and the Health Ministry.
  • Authorities warned the shortages could constitute crimes against public health and omission of functions, urging immediate purchasing to protect patient care.
  • Patients reported prolonged shortages that disrupted chemotherapy and immunotherapy schedules, forcing some families to buy medicines privately.
  • EsSalud said it provided documentation to prosecutors, reported the hospital pharmacy is 93% supplied, and noted ongoing international purchases via CEABE and temporary stock‑sharing, with procurement expected to conclude between March and April.